Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 1Q Financial Report: Pfizer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

1Q Financial Report: Pfizer

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer

1Q Revenues: $12.7 billion (-3%)

1Q Earnings: $4.1 billion (earnings were $301 million 1Q2005)

Comments: Worldwide sales of Lipitor were $3.1 billion in the quarter, up 3%. Sales of Celebrex were $491 million, up 19%. Lyrica sales were $192 million in the quarter as compared to $20 million in 1Q2005. U.S. approvals in the quarter include: Sutent, Exubera, and Eraxis. The low earnings in 1Q2005 were due to charges related to the withdrawal of Bextra and the tax charge from repatriation of foreign profits.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters